<?xml version="1.0"?>
<Articles JournalTitle="Traditional and Integrative Medicine">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Traditional and Integrative Medicine</JournalTitle>
      <Issn>2476-5104</Issn>
      <Volume>10</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>09</Month>
        <Day>07</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Prophylactic Effectiveness of Coenzyme Q10 for Migraine in Adults: A Systematic Review and Meta-Analysis of Double-Blinded Randomized Clinical Trials</title>
    <FirstPage>228</FirstPage>
    <LastPage>240</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Emna</FirstName>
        <LastName>Ellouz</LastName>
        <affiliation locale="en_US">Neurology Department, University Hospital of Gabes, 6014 Gabes, Tunisia AND Sfax University, Sfax Faculty of Medicine, 3029 Sfax, Tunisia</affiliation>
      </Author>
      <Author>
        <FirstName>Imen</FirstName>
        <LastName>Ketata</LastName>
        <affiliation locale="en_US">Neurology Department, University Hospital of Gabes, 6014 Gabes, Tunisia AND Sfax University, Sfax Faculty of Medicine, 3029 Sfax, Tunisia</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>08</Month>
        <Day>28</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>10</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">We aimed to evaluate the influence of coenzyme Q10 alone (CoQ10) or in association with other nutraceuticals (CoQ10+) on the frequency, severity, duration of migraine attacks, and quality of life. We conducted a meta-analysis and a network meta-analysis (NMA) according to PRISMA 2020. We searched PubMed, Web of Science, Google Scholar, and Europe PMC for eligible studies up to January 2024. We used R software for pooled outcomes. This meta-analysis was registered in PROSPERO (CRD42024499733). Five studies were included, with a total of 326 individuals with confirmed migraine. CoQ10/CoQ10+ was shown to be associated with significant improvement in migraine frequency per month, and migraine duration and severity. NMA indicated that CoQ10 combined with L-carnitine appeared to be more effective than CoQ10 on migraine frequency and severity (SMD= -0.99 [95% CI: -1,68 to -0,29]; SMD= -3.05 [95% CI: -4.05 to -2.04], respectively). CoQ10 associated with L-carnitine yielded the greatest significant decrease in migraine duration compared with placebo; NMA revealed no significant difference between CoQ10, CoQ10 with multivitamin, and CoQ10 with L-carnitine. Our findings suggest that for optimal effectiveness, the use of CoQ10/CoQ10+ should be prolonged for at least 3 months. Using CoQ10 had a significant effect on the improvement of the quality of life of patients with migraine. Our meta-analysis suggested a beneficial effect of CoQ10/CoQ10+ for reducing monthly migraine frequency, severity, and duration, notably when it was associated with L-carnitine. Additionally, CoQ10 significantly improved the quality of life.</abstract>
    <web_url>https://jtim.tums.ac.ir/index.php/jtim/article/view/1728</web_url>
  </Article>
</Articles>
